eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
Abstract Background Eukaryotic translation initiation factor 6 (eIF6) has a crucial function in the maturation of 60S ribosomal subunits, and it controls the initiation of protein translation. Although emerging studies indicate that eIF6 is aberrantly expressed in various types of cancers, the funct...
Main Authors: | Liping Sun, Shuguang Liu, Xiaopai Wang, Xuefeng Zheng, Ya Chen, Hong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-02877-4 |
Similar Items
-
PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
by: Ge S, et al.
Published: (2022-01-01) -
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
by: Tatiana S. Driva, et al.
Published: (2022-03-01) -
CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
by: Xiu-Yan Huang, et al.
Published: (2019-05-01) -
EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway
by: Wang L, et al.
Published: (2019-08-01) -
EIF5A2 Expression in Hepatocellular Carcinoma and Its Relation with Postoperative Survival
by: YANG Qian, et al.
Published: (2021-06-01)